Psychedelic Forum Member Preferences for Carer Experience and Consumption Behavior: Can “Trip Sitters” Help Inform Psychedelic Harm Reduction Services?
Liam Engel, Sascha Thal, Stephen Bright
Contemporary Drug Problems August 29, 2022 DOI: 10.1177/00914509221121420 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Population | People who used psychedelics and posted on The Shroomery and DMT Nexus forums |
| Citations | 29 |
| Key findings | Forum participants valued trip sitters with lived psychedelic experience and also identified a demand for remote trip sitting using online tools. |
Abstract
Background: There is limited research on the provision of harm reduction services to people who use psychedelics. Little is known about provision of care to people consuming psychedelics outside of clinical trials.
Methods: We investigated how people who used psychedelics discussed their preferences for care (or “trip sitting”) on two online forums: The Shroomery and DMT Nexus. A thematic analysis of the discussion was conducted to better understand consumer preferences for harm reduction services and resources.
Results: We identified two key themes: experience and remote sitting. Forum participants valued trip sitters who had experienced psychedelic and other non-ordinary states of consciousness, who had knowledge of the health and medical industry, psychedelic literature and/or had previously cared for other psychedelic consumers. Forum participants also identified the value of consuming a psychedelic without somebody who was in their physical proximity, through communicating their plans to a remote trip sitter. The use of online tools was identified as a way to maximize the benefit of privacy while retaining carer benefits.
Conclusion: Demand for trip sitters with lived psychedelic experience is likely influenced by stigma and empathy. Trip sitters who could relate to the effects of psychedelics assisted consumers in avoiding stigma while vulnerable under the effects of psychedelics. As such, psychedelic harm reduction services should be delivered by peers to ensure care maximizes the benefits of empathy. Psychedelic harm reduction services should consider how remote workers could be employed. There is a clear demand for remote psychedelic care services and to our knowledge this has not yet been explored.
Citations in the library
Cited by 24
- Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice Psychedelic Medicine February 16, 2023
- Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited? International Review of Psychiatry June 12, 2024
- Experiential Training in Psychedelic-Assisted Therapy: A Risk-Benefit Analysis. The Hastings Center Report July 1, 2024
- Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts Journal of Psychoactive Drugs September 13, 2024
- EMBARK Psychedelic Therapy for Depression March 6, 2024
and 19 more in the library
Cites 22
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Frontiers in Pharmacology January 17, 2018
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Journal of Psychopharmacology November 18, 2016
- The hidden therapist: evidence for a central role of music in psychedelic therapy Psychopharmacology February 1, 2018
and 17 more in the library